41087811000001107: Bicalutamide 50mg tablets (Bristol Laboratories Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual medicinal product\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet\Bicalutamide 50mg tablets (Bristol Laboratories Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2462321000001118 Bicalutamide 50mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2462341000001111 Bicalutamide 50mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Is a	Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bicalutamide 50mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2462321000001118	Bicalutamide 50mg tablets (Bristol Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2462341000001111	Bicalutamide 50mg tablets (Bristol Laboratories Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module